Susannah Gray
Director/Board Member chez THERAVANCE BIOPHARMA, INC.
Fortune : 146 M $ au 31/03/2024
Profil
Ms. Susannah Gray is an Independent Director at Theravance Biopharma, Inc., an Independent Director at Morphic Holding, Inc., an Independent Director at Maravai Lifesciences Holdings, Inc. and an Independent Director at 4D Molecular Therapeutics, Inc. She is on the Board of Directors at Theravance Biopharma, Inc., Morphic Holding, Inc., Morphic Therapeutic, Inc., Maravai Lifesciences Holdings, Inc., 4D Molecular Therapeutics, Inc., Biosplice LLC, Biosplice Therapeutics, Inc., Colby College Museum of Art, Maravai Life Sciences, Inc., StreetSquash, Susan G.
Komen Foundation, The German Marshall Fund of United States and Wesleyan University.
Ms. Gray was previously employed as an Independent Director by Apria, Inc., an Executive Vice President-Finance & Strategy by Royalty Pharma Management LLC, an Executive Vice President-Finance & Strategy by RP Management LLC, an Analyst by CIBC World Markets Corp.
(Old), and a Managing Director by Merrill Lynch & Co., Inc. /Old/.
She also served on the board at Susan G.
Komen for the Cure.
She received her undergraduate degree from Wesleyan University and an MBA from Columbia Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RPI US Partners 2019 LP
2,24% | 16/06/2020 | 4 788 526 ( 2,24% ) | 145 M $ | 31/03/2024 |
| 17/07/2023 | 60 123 ( 0,05% ) | 521 266 $ | 31/03/2024 | |
THERAVANCE BIOPHARMA INC
0,04% | 02/05/2023 | 20 951 ( 0,04% ) | 187 930 $ | 31/03/2024 |
| 23/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 | |
MORPHIC HOLDING, INC.
-.--% | 01/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Susannah Gray
| Sociétés | Poste | Début |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Director/Board Member | 01/07/2020 |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Director/Board Member | 01/11/2020 |
| MORPHIC HOLDING, INC. | Director/Board Member | 27/04/2021 |
| THERAVANCE BIOPHARMA, INC. | Director/Board Member | 26/02/2023 |
Biosplice Therapeutics, Inc.
 Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Director/Board Member | - |
Maravai Life Sciences, Inc.
 Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Director/Board Member | - |
| Biosplice LLC | Director/Board Member | - |
The German Marshall Fund of United States
 The German Marshall Fund of United States Miscellaneous Commercial ServicesCommercial Services The German Marshall Fund of United States is a faith-based organization founded in 2003 by Richard L. Hamlet. The private company is based in the United States and has subsidiaries in various countries. The organization aims to connect individuals, businesses, and churches to reach the unreached world with the gospel and to minister to those in need. The American company sponsors over 40 gospel-centered evangelism, church planting, and discipleship ministries in over 30 different countries. In addition to their philanthropic efforts, GMF Capital LLC is a privately-owned alternative investment platform that invests in direct venture capital, crypto & blockchain, private equity, and real estate. | Director/Board Member | - |
| Wesleyan University | Director/Board Member | - |
| ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░ ░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Anciens postes connus de Susannah Gray
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░ ░░░░░ ░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░ ░░░░░░░ ░░░░░ ░░░░░ | ░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Susannah Gray
| Wesleyan University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| MORPHIC HOLDING, INC. | Health Technology |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Health Technology |
| Entreprise privées | 13 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
 Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch & Co., Inc. provided wealth management, securities trading and sales, corporate finance and investment banking services. Merrill Lynch was a global trader and underwriter of securities and derivatives across a range of asset classes and serve as a strategic advisor to governments, institutions and individuals worldwide. The company was founded in 1913 and was headquartered in Charlotte, NC. | Finance |
CIBC World Markets Corp. (Old)
 CIBC World Markets Corp. (Old) Financial ConglomeratesFinance CIBC World Markets is a full-service investment bank headquartered in New York City. CIBC provides an internationally integrated research product through three primary strategies. In the US, the firm provides research coverage available in areas of focus, including technology, telecommunications, healthcare, energy, power generation and technology, financial institutions, consumer growth, real estate and media. In Canada, the firm offers the full spectrum of coverage for all of the sectors that form the TSE 300 Index. Their broad investment grade analysis of return bond Indices provides daily performance of the Canadian bond market. The sectors covered are: government of Canada bonds, provincial and municipal bonds and corporate bonds rated AAA/AA, A and BBB. Also available is a monthly ABS/MBS market report that provides information on ABS market conditions, market summary data and monthly performance reports on outstanding transactions. This report includes information about the MBS market, including key statistics on MBS spreads and prepayments. Another report contains MBS trading data, cash flows and other key data. A separate monthly Portfolio Valuation Report provides month end pricing for ABS and MBS transactions. Corporate debt research produces highly targeted credit analysis and research for investment grade and high yield debt securities. The corporate bond review covers bond market action, new issues, price/yield movements, rating changes, and buy/sell recommendations. The fixed-income research group produces actionable fundamental and technical analysis, strategies, products, and runs bond indexes and quantitative models relating specifically to fixed income markets, bond portfolios, and individual securities. CIBC provides risk management solutions to corporations, investors, financial institutions, and governments across all asset classes: interest rates, equities, credit, currency, and commodities. CIBC World Markets is a subsidiary of Canadian Imperial Bank of Commerce. | Finance |
The German Marshall Fund of United States
The German Marshall Fund of United States Miscellaneous Commercial ServicesCommercial Services The German Marshall Fund of United States is a faith-based organization founded in 2003 by Richard L. Hamlet. The private company is based in the United States and has subsidiaries in various countries. The organization aims to connect individuals, businesses, and churches to reach the unreached world with the gospel and to minister to those in need. The American company sponsors over 40 gospel-centered evangelism, church planting, and discipleship ministries in over 30 different countries. In addition to their philanthropic efforts, GMF Capital LLC is a privately-owned alternative investment platform that invests in direct venture capital, crypto & blockchain, private equity, and real estate. | Commercial Services |
StreetSquash
 StreetSquash Services to the Health IndustryHealth Services StreetSquash provides long-term services for children and families. The non-profit company is based in New York, NY. | Health Services |
Susan G. Komen for the Cure
 Susan G. Komen for the Cure Miscellaneous Commercial ServicesCommercial Services Susan G. Komen for the Cure conducts research for breast cancer treatment. It is an non-profit organization engages in breast cancer cure research and fund raising activities. The company was founded by Nancy Goodman Brinker in 1982 and is headquartered in Dallas, TX. | Commercial Services |
RP Management LLC
 RP Management LLC Miscellaneous Commercial ServicesCommercial Services RP Management LLC provides pharmaceutical royalty liquidity services. It provides liquidity to holders of interests in revenue-producing intellectual property in biopharmaceutical products and finances the clinical development of biopharmaceutical products in exchange for a royalty interest. The firm serves research institutions, inventors, and biotechnology and pharmaceutical companies. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY. | Commercial Services |
Maravai Life Sciences, Inc.
Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Finance |
Biosplice Therapeutics, Inc.
Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Commercial Services |
| Susan G. Komen Foundation | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
Apria, Inc.
 Apria, Inc. Medical/Nursing ServicesHealth Services Apria, Inc. engages in the provision of healthcare services. The company was founded on March 22, 2018 and is headquartered in Indianapolis, IN. | Health Services |
Royalty Pharma Management LLC
 Royalty Pharma Management LLC Financial ConglomeratesFinance Royalty Pharma Management LLC engages in funding in the biopharmaceutical industry. The private company is located in the US. | Finance |
| Biosplice LLC |
